Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Companies / B•••••••• I•••

B•••••••• I•••

Series BNew York, NYg•••••••••.comOther
Facts
Year of incorporation
2019sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
3
Disclosed raised
$40.0Msum of rounds with a disclosed amount only
Named investors
4
Financing history
3 rounds
  1. Jan 21, 2026
    Series B · $40.0M (disclosed)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “Benepass Raises $40M Series B to Help Employers Redesign Benefits for Rising Healthcare Costs
  2. Nov 21, 2025
    Form D equity offering · $40.0M (form d sold) · 5 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “B•••••••• I••• filed Form D: $39,999,997 sold of $39,999,997, Other
  3. Dec 22, 2023
    Form D equity offering · $20.0M (form d sold) · 5 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “B•••••••• I••• filed Form D: $19,999,989 sold of $19,999,989, Other
Investors on record
4 edges
People
1 officers, 5 directors
Timeline
3
  1. Jan 21, 2026
    Benepass announced Series B of $40,000,000, led by C•••••• G••••• P•••••••
  2. Dec 5, 2025
    B•••••••• I••• filed Form D: $39,999,997 sold of $39,999,997, Other
  3. Feb 6, 2024
    B•••••••• I••• filed Form D: $19,999,989 sold of $19,999,989, Other
Evidence
32 observations
Every observation on this company